Surrogate Moms Have Higher Rates of Pregnancy Complications
By Dennis Thompson HealthDay Reporter
TUESDAY, Sept. 24, 2024 -- Surrogate moms have a higher risk of pregnancy complications than other pregnant women, a new study finds.
About 8% of surrogate mothers developed a severe complication like high blood pressure or serious bleeding during delivery, Canadian researchers report.
By comparison, only 2% of women who conceive naturally and 4% of women who conceive via IVF develop similar complications, researchers found.
This is one of the first large-scale studies to compare outcomes between the three different types of pregnancy, they noted.
“Clinicians involved in the care of individuals and couples who need a gestational carrier to build their family should counsel their patients and the gestational carriers about the potential risk during pregnancy and early postpartum,” said lead researcher Dr. Maria Velez, an adjunct scientist with the Institute for Clinical Evaluative Services in Kingston, Ontario.
For the study, researchers analyzed data on more than 863,000 births in Ontario, Canada, between 2012 and 2021. Nearly 98% of pregnancies involved natural conception, compared with 1.8% conception with IVF and 0.1% a surrogate.
Overall risk of complications is higher for surrogates, researchers found, and surrogates have a specifically higher risk of high blood pressure and bleeding after delivery.
Surrogates were also more likely to have a preterm birth, results show.
The new study was published Sept. 23 in the Annals of Internal Medicine.
Further study is needed to figure out why surrogate moms are at greater risk for complications, researchers said.
“There are guidelines about the eligibility criteria to minimize the risk of pregnancy complications among gestational carriers,” Velez said in an institute news release. “However, these guidelines are not always strictly followed.”
Sources
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-09-25 06:00
Read more
- ASN: Empagliflozin Offers Lasting Cardiorenal Benefit in CKD Patients
- NIH Trial of Rectal Microbicide for HIV Prevention Begins in the United States
- Vaping Rates Hit Record Lows for U.S. High School Students
- IDSA: 1999 to 2019 Saw Decrease in Sepsis-Related Mortality Rate in Children
- FDA Approves Hympavzi for Hemophilia
- 80.5 Percent of Teens Experience at Least One Adverse Childhood Experience
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions